SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19453287
Source:
http://linkedlifedata.com/resource/pubmed/id/19453287
Search
Subject
(
42
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013227
,
umls-concept:C0546837
pubmed:issue
2
pubmed:dateCreated
2009-6-12
pubmed:abstractText
Cancer of the esophagus and gastro-esophageal junction is a disorder with a poor prognosis and increasing incidence.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101135662
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Investigational
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1744-7623
pubmed:author
pubmed-author:HomsMarjolein Y VMY
,
pubmed-author:SiersemaPeter DPD
,
pubmed-author:VoestEmile EEE
pubmed:issnType
Electronic
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
329-39
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:19453287-Angiogenesis Inhibitors
,
pubmed-meshheading:19453287-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:19453287-Apoptosis
,
pubmed-meshheading:19453287-Clinical Trials as Topic
,
pubmed-meshheading:19453287-Combined Modality Therapy
,
pubmed-meshheading:19453287-Cyclooxygenase 2 Inhibitors
,
pubmed-meshheading:19453287-Drug Delivery Systems
,
pubmed-meshheading:19453287-Drugs, Investigational
,
pubmed-meshheading:19453287-Esophageal Neoplasms
,
pubmed-meshheading:19453287-Humans
,
pubmed-meshheading:19453287-Palliative Care
,
pubmed-meshheading:19453287-Receptor, Epidermal Growth Factor
pubmed:year
2009
pubmed:articleTitle
Emerging drugs for esophageal cancer.
pubmed:affiliation
University Medical Center Utrecht, Department of Medical Oncology, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
pubmed:publicationType
Journal Article
,
Review